Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duodopa in advanced Parkinson's disease health economic evaluation
NCT00272688Phase 4Completed
- Start
- Jan 2006
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levodopa in Parkinson's disease (PD). Primary endpoints: Marginal cost per Quality-Adjusted Life Year at 1 year, Nottingham Health Profile at 12 months and 1 more. Started Jan 2006; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00272688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00272688.